The company's capital structure is increasingly reliant on external financing, with total assets expanding to $90.5M by 2026Q1 while retained earnings have eroded to -$59.4M.
| Total Current Assets | 66.26M | 48.8M | 27.42M | 18.38M | 4.1M | 408.06K | 163K | 34.76K | 41.55K | 463.03K | 248.68K |
| Cash & Short-Term Investments | 15.98M | 3.21M | 466.5K | 7.03M | 217.18K | 405.77K | 160.71K | 28.47K | 35.72K | 452.57K | 248.22K |
| Cash Only | 15.98M | 3.21M | 466.5K | 7.03M | 217.18K | 405.77K | 160.71K | 28.47K | 35.72K | 452.57K | 248.22K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 21.32M | 12.4M | 7.16M | 1.65M | 2.49M | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | 97.36 | 106.52 | 126.52 | 102.26 | 623.85 | - | - | - | - | - | - |
| Inventory | 17.07M | 17.06M | 10.21M | 6.33M | 904.1K | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | 264.3 | 271.5 | 305.44 | 447.02 | 340.65 | - | - | - | - | - | - |
| Other Current Assets | 11.9M | 16.13M | 5.84M | 3.38M | 57.45K | 0 | 0 | 6.29K | 0 | 0 | 0 |
| Total Non-Current Assets | 24.29M | 25.43M | 14.97M | 7.1M | 2.89M | 20.54K | 154.87K | 97.76K | 103.89K | 46.93K | 43.55K |
| Property, Plant & Equipment | 11.33M | 11.85M | 8.01M | 2.99M | 1.92M | 20.54K | 38.21K | 84.64K | 35.34K | 3.38K | 0 |
| Fixed Asset Turnover | 4.32x | 3.58x | 2.58x | 1.97x | 0.76x | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 36.12K | 36.12K | 0 | 1.12K | 13.12K | 0 | 0 | 0 |
| Long-Term Investments | 21.08M | 9.03M | 3.62M | 2.64M | 0 | 0 | 115.54K | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 12.15M | 4.01M | 3.34M | 1.43M | 934.05K | 0 | 0 | 0 | 68.55K | 43.55K | 0 |
| Total Assets | 90.55M | 74.23M | 42.39M | 25.48M | 6.98M | 428.61K | 317.87K | 132.52K | 145.43K | 509.96K | 292.23K |
| Asset Turnover | 0.64x | 0.57x | 0.49x | 0.23x | 0.21x | - | - | - | - | - | - |
| Asset Growth % | 298.02% | 75.12% | 66.35% | 265% | 1528.66% | 34.84% | 139.86% | -8.88% | -71.48% | 74.51% | - |
| Total Current Liabilities | 26.05M | 26.24M | 21.33M | 9.27M | 7.77M | 287.28K | 1.19M | 1.2M | 449.78K | 408.87K | 647.29K |
| Accounts Payable | 4.4M | 5.13M | 2.89M | 900.9K | 165.48K | 124.58K | 131.72K | 141.42K | 10.02K | 6.07K | 54.83K |
| Days Payables Outstanding | 79.8 | 81.58 | 86.39 | 63.65 | 62.35 | 2.42K | 1.28K | 1.37K | 187.91 | 2.81K | - |
| Short-Term Debt | 576.24K | 579.17K | 15.44M | 6.02M | 6.24M | 145K | 195K | 457.5K | 30K | 0 | 480K |
| Deferred Revenue (Current) | 11.77M | 3.27M | 1.28M | 0 | 1.78K | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 17.48M | 17.27M | 0 | 20.48K | 0 | 0 | 188.7K | 104.04K | 259.76K | 320.3K | 44.97K |
| Current Ratio | 2.54x | 1.86x | 1.29x | 1.98x | 0.53x | 1.42x | 0.14x | 0.03x | 0.09x | 1.13x | 0.38x |
| Quick Ratio | 1.89x | 1.21x | 0.81x | 1.30x | 0.41x | 1.42x | 0.14x | 0.03x | 0.09x | 1.13x | 0.38x |
| Cash Conversion Cycle | 281.86 | 296.44 | 345.57 | 485.63 | 902.15 | - | - | - | - | - | - |
| Total Non-Current Liabilities | 9.98M | 9.77M | 7.6M | 1.91M | 1.89M | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Debt | 2.09M | 2.34M | 0 | 0 | 469.02K | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 7.06M | 0 | 2.35M | 1.91M | 1.37M | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 7.89M | 288.76K | 74.82K | 0 | 10.63K | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 36.02M | 36.01M | 28.93M | 11.18M | 9.66M | 287.28K | 1.19M | 1.2M | 449.78K | 408.87K | 647.29K |
| Total Debt | 2.66M | 2.92M | 18.2M | 8.22M | 8.27M | 145K | 195K | 457.5K | 15K | 0 | 480K |
| Net Debt | -13.32M | -289.54K | 17.74M | 1.19M | 8.05M | -260.77K | 34.29K | 429.03K | -20.72K | -452.57K | 231.78K |
| Debt / Equity | 0.05x | 0.08x | 1.35x | 0.57x | - | 1.03x | - | - | - | - | - |
| Debt / EBITDA | -0.54x | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | 2.70x | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -5.34x | -6.36x | -18.68x | -39.01x | -33.58x | - | -1061.02x | - | - | -37.43x | -20.54x |
| Total Equity | 54.52M | 38.22M | 13.46M | 14.3M | -2.68M | 141.33K | -869.05K | -1.06M | -304.35K | 101.09K | -355.06K |
| Equity Growth % | 588.33% | 184% | -5.88% | 633.8% | -1995.29% | 116.26% | 18.27% | -249.35% | -401.06% | 128.47% | - |
| Book Value per Share | 0.27 | 0.19 | 0.07 | 0.11 | -0.67 | 0.05 | -0.37 | -0.49 | -0.15 | 0.05 | -0.19 |
| Total Shareholders' Equity | 54.52M | 38.22M | 13.46M | 14.3M | -2.68M | 141.33K | -869.05K | -1.06M | -304.35K | 101.09K | -355.06K |
| Common Stock | 20.01K | 19.42K | 17.16K | 67.07K | 12.82K | 462.3K | 103.5K | 2.19K | 2.1K | 2.06K | 1.9K |
| Retained Earnings | -59.37M | -55.79M | -43.66M | -35.33M | -3.63M | -8.48M | -6.99M | -5.87M | -2.48M | -1.52M | -485.05K |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | -26K | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -3.57M | -1.12M | 150.29K | 704.42K | 954.52K | 0 | 0 | 254.56K | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Insufficient liquidity for scale
As reported in recent financial filings, SSII's total assets grew from $25.5M in 2023Q4 to $90.5M by 2026Q1, yet this expansion is heavily reliant on external financing rather than internal capital generation, signaling a high-risk trajectory that remains dependent on continuous, potentially dilutive, capital market access.
The rapid asset accumulation appears to be driven by aggressive inventory and equipment deployment rather than organic cash generation. Investors should monitor whether this asset growth translates into sustainable revenue, as the current trajectory suggests a business model that requires constant capital injections to maintain its operational footprint.
Based on the company's reported figures, the debt-to-equity ratio fluctuated significantly from 0.57 in 2023Q4 to a low of 0.05 in 2026Q1, indicating that management has actively managed leverage levels, likely through equity-linked financing to avoid the constraints of traditional debt service obligations.
While the low debt-to-equity ratio might appear favorable, it masks the underlying reality that the company lacks the cash flow to support significant debt. The reliance on equity to manage the balance sheet suggests that the company's cost of capital is likely high and that future growth will continue to dilute existing shareholders.
According to the latest quarterly data, SSII's cash position plummeted to $3.2M in 2025Q4 from $16.0M in 2026Q1, highlighting a severe liquidity crunch that leaves the company with a very thin buffer against operational shocks or delays in its global commercial rollout strategy.
The current ratio of 1.86 in 2025Q4 suggests that while the company has sufficient short-term assets to cover immediate liabilities, the rapid depletion of cash reserves warrants significant concern. This liquidity profile implies that the company may be forced to raise capital under unfavorable terms to sustain its current burn rate.
As indicated by the persistent negative retained earnings, which reached -$59.4M in 2026Q1, the company's equity base is being eroded by ongoing operational losses, necessitating frequent capital raises that appear to be the primary driver of the company's ability to remain a going concern.
The quality of equity is currently strained by the lack of profitability, as the company has yet to demonstrate a path to positive retained earnings. Investors should be wary of the potential for continued share issuance, which may be required to offset the persistent cash burn and support the company's ambitious growth objectives.
Based on the provided balance sheet, the absence of significant goodwill or intangible assets suggests that the company's valuation is tied almost entirely to its physical assets and R&D-heavy cost structure, which may be vulnerable to rapid obsolescence in the competitive robotic surgery market.
The reliance on physical assets like PPE, which grew to $11.3M in 2026Q1, implies that the company is capital-intensive and lacks the flexibility of a software-driven model. This asset-heavy approach creates a significant risk if the SSI Mantra system fails to achieve widespread clinical adoption or regulatory approval in key markets.
Quick answers to the most common questions about buying SSII stock.
As of 2025, SS Innovations International, Inc. (SSII) had total assets of $74.2M including $48.8M in current assets.
SS Innovations International, Inc. (SSII) carries total debt of $2.9M, offset by $3.2M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
SS Innovations International, Inc. (SSII) has total shareholders' equity (book value) of $38.2M ($0.19 book value per share). Book value represents the net worth of the company belonging to common stock holders.
SS Innovations International, Inc. (SSII) reported a current ratio of 1.86x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.